Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pierson

Showing results (281-290 of 322) with videos related to

Pageof 33
Sort By:
Science Translational Medicine|October 29, 2020
Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at 1 year postpartumKevin M Vannella, Sydney Stein, Mark Connelly, et al.
Vaccine|April 23, 2021
Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccineBenjamin C Pierson, Anthony P Cardile, Arthur C Okwesili, et al.
Frontiers in Immunology|March 18, 2021
Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease PatientsAhmed S Fahad, Morgan R Timm, Bharat Madan, et al.
Nature Communications|April 20, 2021
Phenological shifts in lake stratification under climate changeR Iestyn Woolway, Sapna Sharma, Gesa A Weyhenmeyer, et al.
NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Environmental Science & Technology|September 7, 2016
Automatic High Frequency Monitoring for Improved Lake and Reservoir ManagementRafael Marcé, Glen George, Paola Buscarinu, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Science Translational Medicine|April 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite proteinNeville K Kisalu, Lais D Silva Pereira, Jonathan D Herman, et al.
Cell|July 15, 2017
Vaccine Mediated Protection Against Zika Virus-Induced Congenital DiseaseJustin M Richner, Brett W Jagger, Chao Shan, et al.
Clinical Pharmacology and Therapeutics|February 7, 2016
Implementation of a pharmacogenomics consult service to support the INGENIOUS trialM T Eadon, Z Desta, K D Levy, et al.
Pageof 33

Showing results (281-290 of 322) with videos related to

Sort By:
Pageof 33
Science Translational Medicine|October 29, 2020
Nonhuman primates exposed to Zika virus in utero are not protected against reinfection at 1 year postpartumKevin M Vannella, Sydney Stein, Mark Connelly, et al.
Vaccine|April 23, 2021
Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccineBenjamin C Pierson, Anthony P Cardile, Arthur C Okwesili, et al.
Frontiers in Immunology|March 18, 2021
Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease PatientsAhmed S Fahad, Morgan R Timm, Bharat Madan, et al.
Nature Communications|April 20, 2021
Phenological shifts in lake stratification under climate changeR Iestyn Woolway, Sapna Sharma, Gesa A Weyhenmeyer, et al.
NPJ Vaccines|April 27, 2026
Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21Prabhanshu Tripathi, Ja-Hyun Koo, Xuejun Chen, et al.
Environmental Science & Technology|September 7, 2016
Automatic High Frequency Monitoring for Improved Lake and Reservoir ManagementRafael Marcé, Glen George, Paola Buscarinu, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Science Translational Medicine|April 23, 2025
FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting <i>Plasmodium falciparum</i> circumsporozoite proteinNeville K Kisalu, Lais D Silva Pereira, Jonathan D Herman, et al.
Cell|July 15, 2017
Vaccine Mediated Protection Against Zika Virus-Induced Congenital DiseaseJustin M Richner, Brett W Jagger, Chao Shan, et al.
Clinical Pharmacology and Therapeutics|February 7, 2016
Implementation of a pharmacogenomics consult service to support the INGENIOUS trialM T Eadon, Z Desta, K D Levy, et al.
Pageof 33